Textbook of Pharmaceutical Medicine warns of trial risks

BMJ

Volumn 332, Issue 7548, 2006, Pages 1035-

  Chan, chek C ^a  

^a Bracken Ridge Family Practice   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY TGN1412; MONOCLONAL ANTIBODY TG1412; UNCLASSIFIED DRUG;

CLINICAL TRIAL; HUMAN; NOTE; STANDARD; DRUG INFUSION; LETTER; MEDICAL LITERATURE; MEDICINE; PHARMACY; PRIORITY JOURNAL; RISK ASSESSMENT; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS; HUMANS;

EID: 33646456932     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.332.7548.1035     Document Type: Letter

References (2)

1. Mayor S. Inquiry into adverse events in trial blames drug, not study design. BMJ 2006; 332: 870. (15 April.)
2. Posner J. In: Textbook of pharmaceutical medicine. 4th ed. London: BMJ Books, 2002: 205–6.